Table 1

Donor details

Group

Donor

Sex

Age

LVEF (%)

Therapeutic history


Cont (BT)

1

F

42

N/A

N.K.

Cont (SAH)

2

F

48

N/A

N.K.

Cont (SAH)

3

F

51

N/A

N.K.

Cont (HT)

4

M

31

N/A

N.K.

Cont (SEP)

5

F

3

N/A

N.K.

Cont (SAH)

6

M

25

N/A

N.K.

Cont (HT)

7

F

23

N/A

A-DE; A-DI; BET; SYM

Cont (SAH)

8

M

25

N/A

N.K.

Cont (SAH)

9

M

50

N/A

N.K.

IDC

10

M

49

11

ACE; CAL; DIG; DIU

IDC

11

M

64

17

ACE; A-CO; CAL; DIG; DIU; NIT

IDC

12

M

19

N/A

LVAD

IDC

13

M

41

5

A-AR; ACE; A-CO; A-IN; DIU

IDC

14

M

58

24

ACE; A-CO; ALD; DIU; XAN

IDC

15

M

52

28

A-AR; ACE; A-HI; AST; DIU;

IDC

16

M

17

N/A

LVAD. DIU; SYM

IDC

17

M

56

16

ACE; A-CO; A-IN; DIG; DIU

IDC

18

M

17

N/A

ACE; DIU; PDE; SYM

IDC

19

F

58

20

ACE; A-CO; DIU; NIT

IDC

20

M

51

27

A-CO; ALD; ANG; DIU;

ICM

21

F

60

25

ACE; DIG; DIU; LIP

ICM

22

M

48

15

ACE; A-CO; DIU;

ICM

23

F

51

57

A-IN; BET; CAL; LIP; NIT

ICM

24

M

56

13

ACE; A-DI; A-IN; DIU; LIP

ICM

25

M

54

21

A-AR; ACE; A-IN; DIG; DIU; LIP

ICM

26

M

56

30

A-HI; A-IN; DIU

ICM

27

F

55

N/A

ACE; A-DE; A-DI; ALD; DIU

ICM

28

M

48

15

ACE; DIU; LIP

ICM

29

F

62

20.5

A-AR; ACE; ALD; A-IN; DIU; LIP

ICM

30

M

56

18

A-NE; DIG; DIU

ICM

31

M

56

N/A

A-CO; ALD; ANG; DIG; DIU; LIP

ICM

32

M

50

10

ACE; A-CO; ALD; DIG; DIU


LVEF, Left ventricular ejection fraction. Cont, Control (cause of death is shown in parentheses); IDC, idiopathic dilated cardiomyopathy; ICM, ischemic cardiomyopathy; BT, brain tumour; SAH, subarachnoid haemorrhage; HT, head trauma; SEP, sepsis following rupture of appendix. N/A, not available. LVAD, Left ventricular assist device. N.K., Not known. ACE, ACE inhibitor; ALD, Aldosterone antagonist; A-AR, Anti-arrhythmic; A-CO, Anti-coagulation; A-DE, Anti-depressant; A-DI, Anti-diabetic; A-HI, Anti-histamine; A-IN, Anti-inflammatory; A-NE, Anti-neoplastic; ANG, Angiotensin II receptor antagonist; AST, Asthma treatment; BET, Beta blocker; CAL, Calcium channel blocker; DIG, Digoxin; DIU, Diuretic; LIP, Lipid lowering agent; NIT, Nitrate; PDE, PDE III inhibitor; SYM, Sympathomimetic; XAN, Xanthine oxidase inhibitor.

Goulter et al. BMC Medicine 2004 2:19   doi:10.1186/1741-7015-2-19

Open Data